Ngari, Bunyamwera, Ilesha, and Germiston viruses are among the mosquito-borne human pathogens in the Orthobunyavirus genus, family Bunyaviridae, associated with febrile illness. Although the four orthobunyaviruses have been isolated from mosquito and/or tick vectors sampled from different geographic regions in Kenya, little is known of human exposure in such areas. We conducted a serologic investigation to determine whether orthobunyaviruses commonly infect humans in Kenya. Orthobunyavirus-specific antibodies were detected by plaque reduction neutralization tests in 89 (25.8%) of 345 persons tested. Multivariable analysis revealed age and residence in northeastern Kenya as risk factors. Implementation of acute febrile illness surveillance in northeastern Kenya will help to detect such infections.
Introduction

B
unyamwera virus (BUNV) and Ngari virus (NRIV) have recently been isolated from mosquitoes and ticks in northeastern Kenya (Blaney Jr et al. 2001 , Lwande et al. 2013 , Ochieng et al. 2013 . Likewise, Ilesha virus (ILEV) and Germiston virus (GERV) have previously been isolated from mosquitoes in western Kenya ( Johnson et al. 1977) . These viruses belong to the Orthobunyavirus genus of the family Bunyaviridae and possess a tripartite, single-stranded, negative-sense RNA genome. Some members of the genus including these four viruses are known to cause disease in humans with varying pathological consequences (Karabatsos 1985) .
Although orthobunyaviruses have been isolated from arthropod vectors during surveillance exercises in Kenya, no clear evidence exists for incidence of human infection in this region because diagnostic laboratories seldom test for these infections. Moreover, viruses of this genus comprise a neglected but potentially deadly group of viruses given their potential to undergo genetic reassortment with altered pathogenic manifestations, as evidenced by the recent outbreak of Schmallenberg virus in Europe that resulted in malformations in ruminants (Wisloff et al. 2014 ) and the emergence of NRIV in hemorrhagic fever outbreaks in East Africa (Gerrard et al. 2004 , Briese et al. 2006 . We investigated whether orthobunyaviruses commonly infect humans in three different regions of Kenya, as an indication of past clinical or subclinical infection.
Materials and Methods
The present study obtained specimens from an Integrated Response System for Emerging Infectious Diseases in East Africa, also known as the Arbovirus Incidence and Diversity (AVID) project. This project brought together a consortium of implementing institutions consisting of health, veterinary, wildlife, and vector experts to take an integrated approach to arbovirus surveillance and research. The main aim of the project is to improve the prediction and prevention of Rift Valley fever virus and other emerging arboviruses and to develop a model for response that could be expanded to other emerging diseases in the East African region. The project is interested in the discovery of both known and unknown viruses causing emerging infectious diseases. Serum samples were obtained from 345 febrile patients at three health facilities in Kenya between January, 2009, and April, 2012. Specimens were drawn from patients attending Sangailu Dispensary (n = 94) and Kotile Health Centre (n = 118), the main facilities that serve most of the inhabitants of Ijara subcounty of Garissa County in northeastern Kenya. Specimens were also drawn from the Mai Mahiu Health Centre (n = 133) in Naivasha, a subcounty within Nakuru County of the Rift Valley Province of Kenya, a region from which no isolations of these viruses have been made. Ethical approval was obtained from the Kenya Medical Research Institute, Kenya.
All sera were screened at a dilution of 1:20 by a plaque reduction neutralization test (PRNT) using BUNV (strain GSA/S4/11232), NRIV (strain TND/S1/19801), ILEV, and GERV (both obtained from the Centers for Disease Control and Prevention [CDC] , Fort Collins, CO) as described (Blitvich et al. 2012) . Reactive sera were titrated to determine the highest dilution neutralizing 90% or greater of the virus. For etiological diagnosis, the PRNT 90 antibody titer was required to be four-fold or more higher than that of the other virus tested.
Results
Neutralizing antibodies to any of the four orthobunyaviruses were detected in 89 (25.8%) of 345 study participants. Thirty-three participants (9.6%) had neutralizing antibodies to more than one virus, with PRNT titers ranging from 20 to 640 and the majority of cross-neutralization between ILEV and BUNV (Table 1) . These specimens were titrated and analyzed by comparative PRNT to identify the Orthobunyavirus responsible for seropositivity. Eight specimens were resolved, whereas 25 remained undetermined (Table 1 ). The observed cross-neutralization may represent persons doubly infected years ago, and, as such, trace amounts of antibodies remaining were insufficient to yield a four-fold or more difference in titer between the implicated viruses. Alternatively, there could be other yet to be identified orthobunyaviruses circulating within the same region. Although we did not screen for Shokwe virus, previously isolated in Kenya, antibodies against the virus do not neutralize any of the viruses tested in the current study (Karabatsos 1985) . Additionally, it is possible that some of the patients seropositive for NRIV may have been infected with Batai virus, although this virus has not been isolated in Kenya.
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orthobunyaviruses was significantly higher in Sangailu (52.1%) compared to Kotile (32.2%) ( p < 0.0001), probably due to its close proximity to the Boni Forest National Reserve, whereas Naivasha had the lowest proportion (1.5%).
There was no gender difference in the proportion of participants with neutralizing antibodies against orthobunyaviruses.
Discussion
We found that 25.8% of 345 participants in our study had evidence of Orthobunyavirus exposure. The proportion of neutralizing antibodies was higher in participants 15 year or older, indicating that exposure to these viruses may have occurred during the Rift Valley fever outbreak in 1997-1998, where NRIV was isolated from hemorrhagic cases (Gerrard et al. 2004) . Neutralizing antibodies in participants younger than 10 years may indicate ongoing interepidemic transmission and need to be investigated further. The proportion of participants with neutralizing antibodies increased with age, suggesting endemicity of these viruses in northeastern Kenya. Differences in the proportion of participants with neutralizing antibodies between subcounties can be explained by differences in climatic conditions that may influence economic activities of residents. Pastoralism as a source of livelihood and the nomadic nature of inhabitants of northeastern Kenya may promote the spread of these viruses due to their close interaction with domestic animals and possible interaction of their animals with wild animals (which may be reservoirs of these viruses) during grazing (Lwande et al. 2012) . Additionally, mosquito vectors associated with previous isolations of these viruses, including Aedes (Ae.) mcintoshi, Ae. tricholabis, Ae. ochraceus, Culex pipiens, Anopheles (An.) gambiae, An. phareoensis, Mansoni (Mn) africanus, and Mn. uniformis (Gonzalez and Georges 1988 , Logan et al. 1991 , Traorelamizana et al. 2001 , Crabtree et al. 2009 ), are abundant in northeastern Kenya ) and may likely be transmitters of these viruses. Additionally, we have previously determined that An. gambiae is a competent vector for Bunyamwera and Ngari viruses (Odhiambo et al. 2014) .
All patients in the parent study sought care for unspecified fevers, but we could not determine whether any of these febrile illnesses resulted from infection by these viruses because there was no follow-up to obtain convalescent sample for determination of rise in antibody titer. Moreover, no immunoglobulin M (IgM)-capture enzyme-linked immunosorbent assay (ELISA) for orthobunyavirus diagnosis exists. Additionally, we were unsuccessful in isolation of these viruses from reactive sera by inoculation of reactive sera on confluent Vero cells culture and by reverse transcription (RT)-PCR using Orthobunyavirus genus primers, suggesting that these are likely past infections. However, viremia in humans is known to be transient and of low magnitude, hence RT-PCR may be ineffective for detection of Orthobunyavirus RNA in serum specimens (Blitvich et al. 2012 ). Given our inability to include Shokwe and Batai viruses in our analysis due to biosecurity concerns, definitive, specific diagnosis is limited by a lack of comprehensive diversity in the panel of viruses that were used for PRNT.
Conclusion
The present study demonstrates serological evidence of Orthobunyavirus activity in the Sangailu and Kotile regions of Garissa County in northeastern Kenya, thus requiring inclusion of orthobunyaviruses among the unrecognized causes of illness in humans within the region.
